Michael P. Ryan, MS

Research Reports

Real-World Analysis of Outpatient Rasburicase to Prevent and Manage Tumor Lysis Syndrome in Newly Diagnosed Adults With Leukemia or Lymphoma

03/16/2020

Alex R. Cockerham , PharmD, RPh, MSc;

William Irish , PhD;

Edward Drea , PharmD;

Michael P. Ryan , MS;

Lucio Gordan , MD;

Yvonne Barnes , DNP, RN;

Scott C. Howard , MD, MSc;

Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...

...

03/16/2020

Journal of Clinical Pathways

Original Contribution

Association of Iso-Osmolar vs Low-Osmolar Contrast Media With Major Adverse Renal or Cardiovascular Events in Patients at High Risk for Acute Kidney Injury Undergoing Endovascular Abdominal Aortic Aneurysm Repair

08/01/2021

Anand Prasad , MD, FACC, FSCAI, RPVI;

Amit P. Amin , MD, MSc, MS, MBA;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Michael P. Ryan , MS;

Candace Gunnarsson , EdD;

The purpose of this analysis was to examine the association of iso-osmolar contrast media vs low-osmolar contrast media with major adverse renal or cardiovascular events in patients at high risk of AKI undergoing EVAR.

The purpose of this analysis was...

08/01/2021

Journal of Invasive Cardiology